ICM
GCO icon

Invenomic Capital Management’s Genesco GCO Stock Holding History

Invenomic Capital Management’s Portfolio GCO Stock Details GCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-57,100
Closed -$1.43M – 156
2023
Q2 		$1.43M Buy
+57,100
New +$1.65M 0.07% 125
2021
Q2 		– Sell
-30,614
Closed -$1.45M – 134
2021
Q1 		$1.45M Sell
30,614
-37,874
-55% -$1.63M 0.32% 61
2020
Q4 		$2.06M Buy
68,488
+126
+0.2% +$3.22K 0.53% 38
2020
Q3 		$1.47M Buy
68,362
+49,349
+260% +$966K 0.81% 42
2020
Q2 		$412K Buy
+19,013
New +$351K 0.31% 98

Other funds holding GCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invenomic Capital Management's GCO Position: Q3 2023 in Review

Invenomic Capital Management sold out of Genesco (GCO) in Q3 2023, closing a stake of 57,100 shares — an estimated $1.43M sold.

Invenomic Capital Management first reported a position in GCO in Q2 2020 and held it in 5 quarters. The position peaked at $2.06M in Q4 2020. 121 funds tracked by Wall St. Rank hold GCO as of Q3 2023.

  • Invenomic Capital Management reported no remaining Genesco position as of Q3 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 57,100 Genesco shares in Q3 2023, an estimated $1.43M.
  • Invenomic Capital Management first reported a position in Genesco in Q2 2020 and held it in 5 quarters.
  • Invenomic Capital Management's Genesco position peaked at $2.06M in Q4 2020.
  • 121 funds tracked by Wall St. Rank held Genesco as of Q3 2023.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.